Skip To Main Content

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Myeloma Facts

What is your experience with Dupixent in your practice?

Edition Junior Study - Helping patients with type 1 diabetes (T1D) to find better treatment options

Hear from an expert on how does Dupixent target Underlying Type 2 Inflammation?

Hear from an expert on would you consider a biologic for a Surgery-naïve Patient with CRS with Nasal Polyps?

Type 2 Inflammation is the underlying cause of CRSwNP in 80% of Patients.

There is significant unmet need in the management of PN¹

Look beyond the symptoms to identify and manage Patients with Type 2 Inflammation

What gives you confidence that Dupixent improves patients’ quality of life?

Mechanism of Prurigo Nodularis Disease

In this comprehensive exploration, we delve into the intricate pathophysiology of Prurigo Nodularis (PN), highlighting the pivotal roles of neuronal sensitization, inflammation, and pruritus. This challenging dermatological condition is characterized by dermatological condition histopathologic alterations, including enhanced hypervascularization, epidermal hyperkeratosis, and dermal fibrosis. Explore the connection between PN and the proinflammatory Th2 cytokine IL-13, shedding light on its binding to IL-4R across various skin components.

Cognitive decline – The invisible burden of MS?

Understanding TTP

TTP is a life-threatening thrombotic microangiopathy (TMA) that requires quick diagnosis and urgent treatment. 1,2